학술논문
A phase I trial a FR alpha targeted thymidylate synthase inhibitor CT900 exploring four schedules of treatment in expansion cohorts of patients with high-grade serous ovarian cancer.
Document Type
Journal
Author
Banerjee, Susana N.; Russo, Alvaro Ingles; Biondo, Andrea; Funingana, Ionut-Gabriel; Little, Martin; Prout, Toby; Parmar, Mona; Gurel, Bora; Riisnaes, Ruth; Jenkins, Ben; Hall, Emma; Ainscow, Ed; McIntosh, Stuart; Tunariu, Nina; Minchom, Anna Rachel; Lopez, Juanita Suzanne; De Bono, Johann S.; Cook, Natalie; Basu, Bristi; Banerji, Udai
Source
Subject
Language
English
ISSN
15277755